Cargando…

Prognosis of Non-small-cell Lung Cancer Patients With Lipid Metabolism Pathway Alternations to Immunotherapy

Immune checkpoint inhibitors (ICIs) significantly improve the survival of patients with non-small-cell lung cancer (NSCLC), but only some patients obtain clinical benefits. Predictive biomarkers for ICIs can accurately identify people who will benefit from immunotherapy. Lipid metabolism signaling p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Tianli, Zhang, Jing, Liu, Danni, Lai, Guorong, Wen, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317604/ https://www.ncbi.nlm.nih.gov/pubmed/34335679 http://dx.doi.org/10.3389/fgene.2021.646362

Ejemplares similares

Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung Cancer
por: Gu, Xinpei, et al.
Publicado: (2022)

Identification of Fatty Acid Metabolism-Related lncRNAs as Biomarkers for Clinical Prognosis and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Wang, Helin, et al.
Publicado: (2022)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy
por: Wang, Jinsong, et al.
Publicado: (2023)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

RNA-Binding Protein IGF2BP1 Associated With Prognosis and Immunotherapy Response in Lung Adenocarcinoma
por: Liu, JinFeng, et al.
Publicado: (2022)

Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Ma, Yiming, et al.
Publicado: (2022)

A novel lipid metabolism-related lncRNA signature predictive of clinical prognosis in cervical cancer
por: Lu, Yanzhen, et al.
Publicado: (2022)

Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients
por: Luo, Ting, et al.
Publicado: (2022)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

An immunogenic cell death-associated classification predictions are important for breast invasive carcinoma prognosis and immunotherapy
por: Liao, Xinghe, et al.
Publicado: (2022)

Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing
por: Gong, Shasha, et al.
Publicado: (2020)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma
por: Liu, Binfeng, et al.
Publicado: (2023)

An effective prognostic model for assessing prognosis of non-small cell lung cancer with brain metastases
por: Wang, Rong, et al.
Publicado: (2023)

Potentials of Non-Invasive (18)F-FDG PET/CT in Immunotherapy Prediction for Non–Small Cell Lung Cancer
por: Liao, Xuhe, et al.
Publicado: (2022)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022)

TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis via EMT Signaling Pathway
por: Shou, Yi, et al.
Publicado: (2022)

A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021)

Systemic Analysis of the Prognosis-Associated Alternative Polyadenylation Events in Breast Cancer
por: Zhang, Yi, et al.
Publicado: (2020)

Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer
por: Jia, Sinong, et al.
Publicado: (2021)

Identification of hub genes related to CD4(+) memory T cell infiltration with gene co-expression network predicts prognosis and immunotherapy effect in colon adenocarcinoma
por: Tang, Lingxue, et al.
Publicado: (2022)

Identification and Elucidation of the Protective isomiRs in Lung Cancer Patient Prognosis
por: Hsieh, Fu-Mei, et al.
Publicado: (2021)

The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer
por: Jiang, Xuefei, et al.
Publicado: (2022)

Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma
por: Li, Pan, et al.
Publicado: (2022)

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)

Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma
por: Mo, Jiantao, et al.
Publicado: (2022)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
por: Wu, Sijia, et al.
Publicado: (2021)

Novel amino acid metabolism‐related gene signature to predict prognosis in clear cell renal cell carcinoma
por: Cheng, Xiaofeng, et al.
Publicado: (2022)

Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung Cancer
por: Guo, Qiang, et al.
Publicado: (2022)

Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer
por: Zhang, Hongxian, et al.
Publicado: (2021)

Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2022)

Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022)

Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients
por: Zou, Yuantao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u4dvvevq7m4crvv5658b1iqvga